Clinicopathologic characteristics of NSCLC patients with uncommon EGFR mutations in Korea

被引：0

作者：

Kang, Hye Seon ^{[1
]}

Kim, Kyu Yeon ^{[2
]}

Lim, Jeong Uk ^{[3
]}

Yeo, Chang Dong ^{[4
]}

Kim, Ju Sang ^{[5
]}

Kim, Seung Joon ^{[6
]}

Lee, Sang Haak ^{[4
]}

机构：

[1] Catholic Univ Korea, Bucheon St Marys Hosp, Resp & Crit Care Med, Bucheon, South Korea

[2] Catholic Univ Korea, Uijeongbu St Marys Hosp, Resp & Crit Care Med, Uijongbu, South Korea

[3] Catholic Univ Korea, Yeoiudo St Marys Hosp, Resp & Crit Care Med, Seoul, South Korea

[4] Catholic Univ Korea, Eunpyeong St Marys Hosp, Resp Sleep & Crit Care Med, Seoul, South Korea

[5] Catholic Univ Korea, Incheon St Marys Hosp, Resp & Crit Care Med, Incheon, South Korea

[6] Catholic Univ Korea, Seoul St Marys Hosp, Resp & Crit Care Med, Seoul, South Korea

来源：

RESPIROLOGY | 2023年 / 28卷

关键词：

D O I：

暂无

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

AO17-5

引用

页码：100 / 100

页数：1

共 50 条

[31] Efficacy and safety of dacomitinib in treatment-naive patients with advanced NSCLC harboring uncommon EGFR mutations
Wu, L.
Pu, X.
Zhou, Y.
Kong, Y.
Chen, B.
Yang, A.
Li, J.
Li, K.
Xu, Y.
ANNALS OF ONCOLOGY, 2023, 34 : S1695 - S1695
[32] Safety and efficacy of aumolertinib treatment in patients with advanced NSCLC harboring uncommon EGFR mutations: Cohort 2
Fang, W.
Bu, Q.
Wang, Q.
Zhao, W.
Wang, L.
Dong, X.
Chen, P.
Wen, Z.
Jia, J.
Jiang, G.
Zhang, L.
ANNALS OF ONCOLOGY, 2022, 33 : S1587 - S1588
[33] Afatinib for the Treatment of NSCLC Harboring Uncommon EGFR Mutations: A Database of 693 Cases
Yang, James Chih-Hsin
Schuler, Martin
Popat, Sanjay
Miura, Satoru
Heeke, Simon
Park, Keunchil
Maerten, Angela
Kim, Edward S.
JOURNAL OF THORACIC ONCOLOGY, 2020, 15 (05) : 803 - 815
[34] Uncommon EGFR mutations in a cohort of Chinese NSCLC patients and outcomes of first-line EGFR-TKIs and platinumbased chemotherapy
Jinpeng Shi
Hui Yang
Tao Jiang
Xuefei Li
Chao Zhao
Limin Zhang
Sha Zhao
Xiaozhen Liu
Yijun Jia
Yan Wang
Lei Xi
Shijia Zhang
Chunxia Su
Shengxiang Ren
Caicun Zhou
Chinese Journal of Cancer Research, 2017, 29 (06) : 543 - 552
[35] FURTHER: A global study to evaluate furmonertinib in patients with EGFR mutant NSCLC including uncommon EGFR mutations (FURMO-002)
Le, Xiuning
Spira, Alexander I.
Gadgeel, Shirish M.
Riess, Jonathan W.
Yu, Yan
Zhao, Yanqiu
Cheng, Ying
Juan-Vidal, Oscar
Gao, Bo
Yoh, Kiyotaka
Forster, Martin
Kitazono, Satoru
Hayashi, Hidetoshi
Planchard, David
Jiang, Yong
Baio, Nichole
Kowanetz, Marcin
Leung, William
Hsu, Jerry Y.
Wang, Jie
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
[36] Uncommon single and compound EGFR mutations: clinical outcomes of a heterogeneous subgroup of NSCLC
Rossi, Sabrina
Damiano, Paola
Toschi, Luca
Finocchiaro, Giovanna
Giordano, Laura
Marinello, Arianna
Bria, Emilio
D'Argento, Ettore
Santoro, Armando
CURRENT PROBLEMS IN CANCER, 2022, 46 (01)
[37] Leptomeningeal Metastases in Patients with NSCLC with EGFR Mutations
Li, Yang-Si
Jiang, Ben-Yuan
Yang, Jin-Ji
Tu, Hai-Yan
Zhou, Qing
Guo, Wei-Bang
Yan, Hong-Hong
Wu, Yi-Long
JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (11) : 1962 - 1969
[38] NSCLC with uncommon EGFR mutations treated with atezolizumab plus bevacizumab and chemotherapy.
Trummer, Arne Rainer
Bethge, Andre
Dickgreber, Nicolas J.
Dittrich, Ina
Golpon, Heiko
Hoffknecht, Petra
Overbeck, Tobias R.
Wesseler, Claas
Reck, Martin
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
[39] Afatinib for the treatment of NSCLC with uncommon EGFR mutations: An updated database of 1023 cases
Yang, J. Y. C-H.
Schuler, M.
Popat, S.
Miura, S.
Park, K.
Passaro, A.
de Marinis, F.
Solca, F.
Marten, A.
Kim, E. S.
ANNALS OF ONCOLOGY, 2021, 32 : S965 - S965
[40] Clinicopathologic characteristics and EGFR mutations in lung cancer patients aged below 45 years
Xia, Jingjing
Li, Hong
Ji, Paling
Mia, Can
Chen, Guilian
Li, Ping
Zhang, Ruirui
Chen, Wei
Wang, Jipeng
CURRENT PROBLEMS IN CANCER, 2019, 43 (04) : 363 - 370

← 1 2 3 4 5 →